Skip to main content

Incident Utilization of Allopurinol, Hydralazine, and Propylthiouracil: A Descriptive Analysis

    Basic Details
    Date Posted
    Status
    Complete
    Medical Product
    allopurinol
    hydralazine
    propylthiouracil
    Description

    This report describes incident use of allopurinol, hydralazine, and propylthiouracil among enrolled members in the Merative™ MarketScan® Research Databases. Incident use is defined using 90-day, 180-day, and 270-day washout periods. Results include counts of incident users and the number of dispensings, among incident users of each drug overall and stratified by age group, year, and generic name. 

    The study period includes data from January 1, 2010 to March 31, 2018. This request was run on the Merative™ MarketScan® Research Databases on October 18, 2019.

    Additional Details
    FDA Center
    CDER
    Time Period
    January 1, 2010 - March 31, 2018
    Analysis Type
    Summary Table
    Population / Cohort
    All individuals
    Data Sources
    Merative™ MarketScan® Research Databases